Injecting mosquitoes with bacterium shows potential for dengue elimination, scientists report

NewsGuard 100/100 Score

Injecting mosquitoes with the Wolbachia bacterium "can block them from transmitting the dengue virus and help control the spread of a disease that kills 20,000 annually in more than 100 countries," a team led by Scott O'Neill, a geneticist at the University of Queensland in Brisbane, reports in two papers published in Nature on Thursday, Reuters reports.  The "researchers in Australia showed how female mosquitoes infected with the Wolbachia bacteria passed the bug easily to their offspring, making them all dengue-free," according to the news agency (Lyn, 8/24). 

"There is no vaccine available [for dengue fever], and patients suffering the intense joint and muscle pain that mark a dengue infection have no treatment options other than painkillers," the Washington Post writes (Vastag, 8/24). "Unlike for malaria, bed nets are not effective in combating dengue as" the mosquito that transmits the disease "is active during the day. And concerns about rising resistance to insecticides has spurred the search for alternatives," Nature notes (Gilbert, 8/24).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
COVID-19 booster enhances virus neutralizing antibodies in breast milk, new study reveals